Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Healthcare Cannabis Cannabis
Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:AVCN)

Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company

GlobeNewswire December 2, 2024

Avicanna Reports Q3 2024

GlobeNewswire November 14, 2024

Avicanna Announces Closing of Non-Brokered Private Placement

GlobeNewswire November 4, 2024

Avicanna announces medical cannabis study through MyMedi.ca  

Jim Wilkie September 23, 2024

Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca  

GlobeNewswire September 23, 2024

Avicanna Announces Repayment of Debentures

GlobeNewswire August 30, 2024

Avicanna Announces Closing of Non-Brokered Private Placement

GlobeNewswire August 28, 2024

Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology

GlobeNewswire August 27, 2024

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark

GlobeNewswire August 15, 2024
View More News ››

Opinion & Analysis (TSX:AVCN)

Disrupting the Cannabinoid Industry with Science and Innovation

Dave Jackson May 10, 2021

This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters

Featured Submission April 21, 2021

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

Isabella Zavarise December 23, 2020
View More Opinion ››

Bullboard Posts (TSX:AVCN)

Excellent coverage on AVCN

https://youtu.be/pc5r8SxJcWs?si=tDqsSQWB0Bm05rVh
BryceCanada - December 1, 2024

RE:RE:RE:RE:Q3 FINS Review (2 / 5 stars)

GFY whiner.
WolfOakville - November 15, 2024

RE:RE:RE:Q3 FINS Review (2 / 5 stars)

1 x revenue for a 57% GM margin, IP/pharma company, you are not assessing an MJ stock though thats the picture you would want to paint...
Dagreedyanalyst - November 15, 2024

RE:RE:Q3 FINS Review (2 / 5 stars)

Let's re-visit this in 6 months. Nonsense is one word and contains no "e" sunshine.  How will they service their...
WolfOakville - November 15, 2024

RE:Q3 FINS Review (2 / 5 stars)

This made my day. Thank you for confirming that someone important and funded enough is naked shorting this stock that got this clown to...
Dagreedyanalyst - November 15, 2024

Q3 FINS Review (2 / 5 stars)

"Expect additional raises, more dilution, and Wolf to stay on the sidelines." Click for full review
WolfOakville - November 15, 2024
View more Bullboard ››

Forsys Metals Corp

Forsys Metals Corp

Forsys Metals Corp. is a Canada-based uranium developer. The Company is engaged in the acquisition, exploration and ...
View More »